Arena Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Arena Pharmaceuticals patents 56 in total

Status Patent
Application
Utility: MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO External link
Filling date: 9 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: Modified-Release Dosage Forms of 5-Ht2c Agonists Useful for Weight Management External link
Filling date: 9 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO External link
Filling date: 9 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO External link
Filling date: 9 Sep 2025 Issue date: 29 Aug 2019
Application
Utility: MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO External link
Filling date: 9 Sep 2025 Issue date: 15 Aug 2019
Application
Utility: COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF External link
Filling date: 9 Sep 2025 Issue date: 8 Aug 2019

Showing 50 to 56 of 56 patents.